Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 3
1975 1
1976 2
1977 1
1978 2
1980 4
1981 4
1982 1
1983 8
1984 3
1985 3
1986 6
1987 7
1988 2
1990 1
1991 5
1992 4
1993 2
1994 5
1996 2
1997 1
1999 1
2011 1
2012 1
2013 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
Transfer factor: a potential agent for cancer therapy.
LoBuglio AF, Neidhart JA. LoBuglio AF, et al. Among authors: neidhart ja. Med Clin North Am. 1976 May;60(3):585-90. doi: 10.1016/s0025-7125(16)31899-5. Med Clin North Am. 1976. PMID: 775210 Review.
A review of transfer factor immunotherapy in cancer.
LoBuglio AF, Neidhart JA. LoBuglio AF, et al. Among authors: neidhart ja. Cancer. 1974 Oct;34(4 Suppl):suppl:1563-70. doi: 10.1002/1097-0142(197410)34:8+<1563::aid-cncr2820340831>3.0.co;2-s. Cancer. 1974. PMID: 4609370 Review. No abstract available.
Low-dose deoxycoformycin in lymphoid malignancy.
Grever MR, Leiby JM, Kraut EH, Wilson HE, Neidhart JA, Wall RL, Balcerzak SP. Grever MR, et al. Among authors: neidhart ja. J Clin Oncol. 1985 Sep;3(9):1196-201. doi: 10.1200/JCO.1985.3.9.1196. J Clin Oncol. 1985. PMID: 2993534
Transfer-factor therapy of malignancy.
Neidhart JA, LoBuglio AF. Neidhart JA, et al. Semin Oncol. 1974 Dec;1(4):379-85. Semin Oncol. 1974. PMID: 4220127 Review. No abstract available.
Immunologic specificity of transfer factor.
Zuckerman KS, Neidhart JA, Balcerzak SP, LoBuglio AF. Zuckerman KS, et al. Among authors: neidhart ja. J Clin Invest. 1974 Oct;54(4):997-1000. doi: 10.1172/JCI107841. J Clin Invest. 1974. PMID: 4139171 Free PMC article.
73 results